IDEX Corp's stock soared 8.76% intraday on Wednesday, following the release of its first-quarter financial results.
The company reported adjusted earnings per share of $2, beating the IBES estimate of $1.77, and sales of $886.9 million, surpassing the estimate of $845.6 million. IDEX also raised its full-year 2026 organic sales growth outlook to 3%-4% from 1%-2% and adjusted diluted EPS guidance to $8.35-$8.55 from $8.15-$8.35.
The strong performance was driven by higher volumes in Health & Science Technologies, fueled by AI-related demand for data center power and semiconductors, as well as strength in space and defense. Positive pricing across all segments also contributed to sales growth.
Comments